Search

everythinglearnresearchcommunity

for

Search:↓

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Clofazimine effectively treated ashy dermatosis in a patient.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Gefitinib can cause hair loss without scarring.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.